अब आप न्यूज्ड हिंदी में पढ़ सकते हैं। यहाँ क्लिक करें
Home » Education » NIPER Hyderabad ‘killing’ MBA Pharma despite industry demand and 100% placements: Students

NIPER Hyderabad ‘killing’ MBA Pharma despite industry demand and 100% placements: Students

A member of the pharmaceutical management department found that there were no seats available for the course.

By Newsd
Published on :
NIPER Hyderabad killing MBA Pharma

NIPER Hyderabad killing MBA Pharma: Students of MBA in Pharmaceutical Management discovered their course was no longer available when the National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad’s admission brochure was published in April.

A member of the pharmaceutical management department found that there were no seats available for the course.

Our batch from NIPER Hyderabad will be the last batch of the course and the department, said a first-year MBA Pharma student.

“There has been no official announcement made but in the recently-shared brochure for admission, the seats of MBA (Pharma) course have come down to zero,” said a teacher from the department. “We have not been told any reason for this. That is the most surprising part.”

Staff and students protested the potential scrapping of NIPER Mohali in February 2024.

The Department of Pharmaceuticals (DoP) under the Ministry of Chemicals and Fertilizers terminated the two-year MBA at NIPER Mohali and replaced it with an MTech-MBA dual-degree program.

Also Read: OJEE 2024 MBA admit card tomorrow at odishajee.com; exam on May 8

Low-cost MBA

Among the few MBA courses in pharmaceutical management, it costs more than Rs 15-20 lakh, even at IIMs [Indian Institutes of Management].

NIPER is the only government institute that offers an MBA for less than Rs 5.5 lakh and is very affordable, with 100% placements.

There is strong industry demand for the MBA Pharma course,” said a student from NIPER Hyderabad who did not wish to be identified.

Alumni of the department have written to the institute requesting that it keep the MBA program.

Their letter said: “The … alumni of NIPER Hyderabad, are writing to understand the recent news regarding the potential abolition of the Pharma MBA course. The proposed discontinuation of the MBA programme risks diluting the essence and core of the MBA programme.”

“This decision will end the dreams of lakhs of B.Pharma students in various pharmacy colleges nationwide who dream of joining this prestigious course and contributing to India’s future.”

“The department has significantly contributed to NIPER Hyderabad, the pharmaceutical industry, and the nation. Abolishing the Pharma MBA course could have a profoundly negative impact on various areas and young professionals.”

NIPER Hyderabad killing MBA Pharma: MBA Pharma at NIPER Mohali

The students of NIPER Mohali received a notification regarding the restructuring of the departments in February 2024.

As a result of the merger with MTech, the pharmaceutical management department will be closed in February 2024.

This course was to be a dual-integrated program in which students would study MTech for two years and MBA for one year, according to the restructuring plan. “We disagreed on this pattern,” said NIPER Mohali’s first-year MBA Pharma student.

Although NIPER Hyderabad was also supposed to undergo restructuring, neither an integrated MTech/MBA program nor an MBA program has been launched.

Also Read: ‘You made victim nymphomaniac’: Bombay HC Denies Bail Plea of Rape Accused

NIPER Ahmedabad does not have any seats either.

NIPER Hyderabad students and faculty are concerned about aspirants who have been waiting to appear for the examination.

Many students will be impacted, especially B Pharma graduates because NIPER-JEE is the examination for all master’s courses at NIPER.

Teachers have said that terminating the course will have a severe impact on the entire industry since the course has 100% placements.

Even though the course has 100% placements, terminating it will affect the industry as a whole.

In addition, the average package has increased from Rs 5 lakh per annum in 2012 to Rs 28 lakh per annum in 2023.”

According to the alumni network, the pharmaceutical industry should also recognize the importance of a dedicated management program to preserve its future.

This is true of the B-schools within IITs, which operate independently, acknowledging the importance of management studies in their respective industries.

The letter said: “The prestigious ICT Mumbai has announced a two-year MBA programme for this academic year, 2024, other institutes are eager to start MBA programmes. It is devastating to note that a well-established, long-standing MBA(Pharma) course is being killed at NIPER Hyderabad and Ahmedabad.”

Also Read: GGSIPU extends counselling deadline for MBA, LLB, LLM programmes till May 20


Latests Posts

Editor's Choice